Indian Researchers Develop Targeted Nano-Formulation to Aid Parkinson’s Disease Management
Mohali: In a groundbreaking advancement, researchers from the Institute of Nano Science and Technology (INST), Mohali, have developed a targeted nano-formulation that enables the sustained release of 17β-Estradiol (E2), a hormone critical for managing Parkinson’s Disease (PD). This innovation holds promise for revolutionizing treatment strategies for the debilitating neurodegenerative condition. Parkinson’s Disease, a progressive neurological…